Twist Bioscience Corporation Common Stock – Quartalsabschluss (NASDAQ:TWST)

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Market Capitalization 3.49 B
Employee 979
Founded 2013
CEO Emily LeProust
Website www.twistbioscience.com
Headquarter Delaware, United States
FIGI BBG006KDCHJ4
Industry Technology

Gesamtumsatz

Jahresüberschuss

Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

3.49 B Marktkapitalisierung

Kurs-Gewinn-Verhältnis

-24.98

Preis-Umsatz-Verhältnis

4.9

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.